Trial
NCT04551573
A Study of the Pharmacokinetic and Pharmacodynamic Interactions Between Bictegravir, Tenofovir Alafenamide and Rifapentine in Healthy Adult Subjects
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Yale University
Collaborators
Gilead Sciences
Condition
Tuberculosis
Intervention
Rifapentine daily
Why stopped
COVID-19 Pandemic
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-09-20